Investors receive warrant coverage; Chardan Capital Markets is agent
By Devika Patel
Knoxville, Tenn., July 5 – Northwest Biotherapeutics, Inc. said it will raise $3.7 million in a registered direct offering of stock. The deal will be conducted through agent Chardan Capital Markets, LLC.
The company will sell about 7.4 million common shares at $0.50 per share. The per-share purchase price is a 16.67% discount to $0.60, the closing price of the stock on July 1.
Investors will also receive warrants for 3.7 million shares. Each warrant is exercisable at $0.60 for five years. The strike price is identical to the July 1 closing price.
Settlement was expected Monday.
Northwest is a development-stage biotechnology company based in Bothell, Wash.
| Issuer: | Northwest Biotherapeutics, Inc.
|
| Issue: | Common stock
|
| Amount: | $3.7 million
|
| Shares: | 7.4 million
|
| Price: | $0.50
|
| Warrants: | For 3.7 million shares
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $0.60
|
| Agent: | Chardan Capital Markets, LLC
|
| Pricing date: | July 5
|
| Settlement date: | July 5
|
| Stock symbol: | Nasdaq: NWBO
|
| Stock price: | $0.60 at close July 1
|
| Market capitalization: | $48.68 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
